Clinical Trial: Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral Neuropathy

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07794475) titled 'Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral Neuropathy' on Aug. 24.

Brief Summary: The goal of this clinical trial is to investigate if trimetazidine can improve clinical outcomes of patients with diabetic peripheral neuropathy. The main questions it aims to answer are:

Does trimetazidine improve the symptoms of diabetic peripheral neuropathy? Does trimetazidine affect endothelin-1 levels?

Participants in the interventional arm will receive trimetazidine tablets 35 mg twice daily for three months.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Diabetic Per...